<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We hypothesized that dexanabinol can prevent neuronal <z:hpo ids='HP_0011420'>death</z:hpo> by protecting neuronal lysosomes from nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO)-mediated toxicity, and in turn, by suppressing the release of cathepsins during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced in two sets of animals by permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The first set was used to monitor NO concentration and cathepsin activity, while the second was used for histological examination with <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin, and TUNEL staining </plain></SENT>
<SENT sid="3" pm="."><plain>In post-ischemic brain tissue, NO content and cathepsin B and L activity increased (p &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Dexanabinol treatment reduced NO concentration and cathepsin activity to the control level (p &gt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The number of eosinophilic and apoptotic neurons increased in the post-ischemic cerebral cortex (p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>However, dexanabinol treatment lowered both of these (p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that dexanabinol might be a useful agent for the treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
</text></document>